今天上午，上证指数盘中最高冲至3669.04点，再创今年以来新高，逼近2024年10月8日的盘中高点3674.4点。伴随指数再创阶段新高，今天上午，几个"老 面孔"盘中股价又创历史新高：农业银行、新易盛（300502）、胜宏科技（300476）、工业富联（601138）。 被网友称为"AI一哥"的寒武纪（688256）上午在各大投资群刷屏。经历早盘震荡调整，10:12左右，寒武纪开始拉升，之后涨幅不断扩大，上午上涨 15.61%，报817.8元/股，时隔5个月，股价重返800元，且逼近前期的历史高点818.87元。寒武纪上午成交额为89.36亿元，居A股第一。在寒武纪拉升过程 中，半导体板块跟随走强，光刻机板块领涨。 上午收盘，上证指数上涨0.51%，深证成指上涨0.34%，创业板指上涨0.91%。 | | | | 兴业银行 | 23.21 | 1.44% | 4912亿 | | --- | --- | --- | --- | | 融 601166 | | | | | 中信银行 | 8.35 | 1.33% | 3404亿 | | 融 601998 | | | | | 民生银行 | 4.95 | 1.23% ...

下跌方面，军工股展开调整，捷强装备等跌超5%。板块方面，脑机接口、港口、新疆、液冷服务器等 板块涨幅居前，锂矿、军工、稀土永磁、光伏等板块跌幅居前。截至收盘，沪指涨0.53%，深成指涨 0.34%，创业板指涨0.91%。 来源：智通财经 今日A股早盘震荡走高，三大指数小幅上涨，沪指再创年内新高。沪深两市半日成交额1.14万亿，较上 个交易日放量585亿。盘面上热点较为杂乱，个股跌多涨少，全市场超3300只个股下跌。 从板块来看，AI硬件股再度大涨，胜宏科技等多股再创历史新高，寒武纪涨超15%。脑机接口概念股表 现活跃，麦澜德涨超10%。新疆本地股维持强势，新疆交建等多股3连板。 ...

1、脑机接口 麦澜德、翔宇医疗、麒盛科技、创新医疗等多股上涨。 消息面上，近日，包括国家卫健委、药监局在内的七部门联合发布了《工业和信息化部国家发展改革委教育部国家卫生健 康委国务院国资委中国科学院国家药监局关于推动脑机接口产业创新发展的实施意见》（下文简称《实施意见》），标志着我 国首次将脑机接口从一个前沿科研领域正式提升为国家级产业战略。 2、液冷服务器 申菱环境、博汇股份、新朋股份、大元泵业等多股上涨。 8月12日消息，三大指数早盘走强，创指半日涨近1%。板块方面，脑机接口概念早盘强势，麦澜德涨超10%领涨；临近午 盘港口航运板块拉升，南京港触及涨停；液冷服务器概念活跃，新朋股份、大元泵业双双涨停；下跌方面，锂矿股陷入回调， 永杉锂业、融捷股份跌幅居前；军工装备板块集体走弱，捷强装备、佳驰科技领跌；稀土永磁板块走低，奔朗新材跌幅居前。 总体来看，个股跌多涨少，下跌个股超3300只。 截至午间收盘，沪指报3666.33点，涨0.51%；深成指报11330.34点，涨0.34%；创指报2401.52点，涨0.91%。 盘面上，燃气、港口航运、脑机接口板块涨幅居前，能源金属、军工装备、稀土永磁板块跌幅居前。 ...

Core Viewpoint - The medical device sector is experiencing significant growth, driven by supportive policies and technological advancements, particularly in brain-computer interface technology and commercial health insurance development [2][4]. Group 1: Medical Device Sector Performance - Medical device stocks such as Mindray, Sanxin Medical, and Maipu Medical have seen increases of over 10%, while others like Xiangyu Medical and Shanhai Mountain have risen over 5%, contributing to the overall rise of medical device ETFs [1]. - The medical device market in China surpassed 1,032.8 billion yuan in 2023, maintaining its position as the second-largest globally, supported by policy backing, aging population, and technological innovation [3]. Group 2: Policy Developments - A joint initiative by seven government departments aims to promote the innovation and development of brain-computer interface technology, targeting breakthroughs by 2027 and establishing a competitive industry ecosystem by 2030 [2][4]. - Shanghai has introduced 18 measures to support the development of commercial health insurance and innovative medical devices, focusing on expanding coverage and integrating new medical technologies into insurance plans [3]. Group 3: Market Outlook - The medical device industry is expected to benefit from the integration of innovative products into insurance coverage, which may enhance market confidence and stimulate growth [5]. - The focus on commercial health insurance and innovative medical devices is anticipated to create new opportunities for investment in the sector, particularly in areas like AI and high-end domestic equipment [3][4].

Market Overview - The three major A-share indices collectively rose, with the Shanghai Composite Index increasing by 0.51%, the Shenzhen Component Index by 0.34%, and the ChiNext Index by 0.91% [1] - The North Star 50 Index declined by 0.33% [1] - The total trading volume in the Shanghai, Shenzhen, and Beijing markets reached 12,101 billion yuan, an increase of 605 billion yuan compared to the previous day [1] - Over 1,800 stocks in the market experienced gains [1] Sector Performance - The gas, port shipping, and brain-computer interface sectors saw significant gains, while the energy metals and military equipment sectors experienced adjustments [1] - In the ETF market, the chip sector surged, with Cambrian Technology rising by 15% [1] - The ETFs related to the chip sector, including the Huatai-PineBridge Science and Technology Chip 50 ETF, increased by 2.76%, while the other two chip ETFs from Guotai and Jiashi rose by 2.71% and 2.7% respectively [1] - Core stocks in the AI hardware sector continued to rise, with Industrial Fulian and several others reaching historical highs [1] - The AI ETFs in the ChiNext, including those from Guotai, Huabao, and Guotai, increased by 2.35%, 2.39%, and 2.25% respectively [1] - The communication equipment sector also saw an upward trend, with the Guotai Communication ETF and the Huaxia 5G Communication ETF rising by 2.5% and 2.05% respectively [1] Declining Sectors - The innovative drug sector experienced a pullback, with the Guotai Innovation Drug ETF declining by 2.7% [1] - The rare metals sector also faced a downturn, with the Rare Metals ETF and another Rare Metals ETF falling by 2.65% and 2.58% respectively [1] - The aerospace and military industry sectors were all in the red, with the Tianhong Aerospace ETF and the Military Industry Leader ETF dropping by 2.1% and 1.93% respectively [1]

Core Viewpoint - The medical device sector is expected to witness a performance turning point from the second half of 2025 to 2026, driven by the continuous improvement in the technological strength and product competitiveness of domestic medical device companies, transitioning from "domestic substitution + penetration enhancement" to "international expansion + technological innovation" [2] Group 1: Policy Improvement and Industry Recovery - Historical performance shows a continuous decline in the medical device sector from 2021 to 2024, with further pressure in 2023-2024 due to upgraded medical compliance requirements and a slowdown in equipment renewal [3] - Signals of recovery are emerging, particularly in high-value consumables, where policy optimization is driving valuation recovery and there is significant room for penetration improvement [4] - In the medical equipment sector, a turning point in bidding growth is expected in Q4 2024, with leading companies' performance stabilizing and accelerating domestic substitution by Q3 2025 [5] - The in vitro diagnostics (IVD) sector is currently under policy pressure, but the chemical luminescence field may stabilize in terms of volume and price by Q4 2026, with significant potential for domestic substitution in the medium to long term [6] - For low-value consumables, attention is needed on overseas production capacity layout and progress with major customer collaborations under tariff policies [7] - The home medical device market, including respiratory machines and continuous glucose monitoring (CGM), presents vast opportunities, with a focus on consumer sentiment and international expansion [8] Group 2: Corporate Strategic Transformation - Companies are focusing on cost reduction and efficiency improvement through large-scale production, process optimization, and supply chain management to maintain profit margins [9] - Technological innovation is key, with differentiated product layouts helping to mitigate procurement risks, and healthcare insurance policies providing longer release cycles for innovative devices [10] - The transformation in consumption patterns shows that the impact of healthcare cost control is minimal, while consumption upgrades drive growth in optional medical demand, indicating a higher market ceiling [11] - International breakthroughs are being made as domestic companies leverage cost and supply chain advantages to accelerate overseas expansion [12] - Mergers and acquisitions are being utilized to break through existing market ceilings and enter emerging fields such as surgical robots and brain-computer interfaces [13] Group 3: Global Leadership in Innovative Medical Devices - Several Chinese companies have achieved technological breakthroughs, leveraging population size, clinical data accumulation, and industrial chain advantages [14] - Notable achievements include the world's first full-body PET/CT by United Imaging, leading chemical luminescence detection speeds by Mindray and New Industries, and the FDA breakthrough designation for Sino Medical's intracranial stent [15] Group 4: Growth Path of Global Medical Device Leaders - The strategy of going global is shifting from domestic substitution to global competition, with local operations and factory construction driving high growth in overseas business [16] - Technological innovation is fueled by R&D investment, with some companies accelerating internationalization through a license-out model [17] - Mergers and acquisitions are seen as a pathway for Chinese companies to release global growth potential, drawing lessons from U.S. medical device giants [18] Group 5: Investment Opportunity Analysis - In the Hong Kong stock market, attention should be paid to companies with strong innovation attributes and license-out potential, as well as undervalued companies with sufficient cash reserves that may turn profitable from 2025 to 2027 [19] - In the A-share market, companies expected to see performance turning points in Q2-Q3 2025 should be monitored, along with those benefiting from optimized procurement policies and new medical technologies [20] - The Chinese medical device industry is transitioning from a "follower" to a "leader," with technological innovation and international expansion becoming core driving forces, positioning leading companies to become world-class benchmarks [20]

(责任编辑：宋政 HN002) 【免责声明】本文仅代表作者本人观点，与和讯网无关。和讯网站对文中陈述、观点判断保持中立，不对所包含内容 的准确性、可靠性或完整性提供任何明示或暗示的保证。请读者仅作参考，并请自行承担全部责任。邮箱： news_center@staff.hexun.com 盘面上，产业创新发展实施意见发布，脑机接口概念走强，麦澜德涨近17%，翔宇医疗涨超10%；港口 航运板块盘中短线拉升，南京港(002040)涨停，国航远洋涨近11%；燃气板块全线上涨，东方环宇 (60370)、新疆火炬(603080)、洪通燃气涨停；地产股普涨，沙河股份(000014)、电子城(600658)涨停， 深振业A涨超8%；银行股集体上涨，农业银行(601288)盘中一度涨近2%续创新高，光大银行(601818)、 工商银行(601398)等涨超1%。 另外，锂矿股回调，永杉锂业、融捷股份(002192)跌超4%，锂业分会倡议抵制"内卷式"恶性竞争；军工 装备板块走低，捷强装备、佳驰科技跌超6%；稀土永磁概念股普跌，奔朗新材跌超5%，盛和资源 (600392)、久吾高科(300631)跌超4%。(格隆汇) 格隆汇8月 ...

另外，锂矿股回调，永杉锂业、融捷股份跌超4%，锂业分会倡议抵制"内卷式"恶性竞争；军工装备板 块走低，捷强装备、佳驰科技跌超6%；稀土永磁概念股普跌，奔朗新材跌超5%，盛和资源、久吾高科 跌超4%。(格隆汇) MACD金叉信号形成，这些股涨势不错！ 格隆汇8月12日｜A股三大指数集体收涨，截至午盘，沪指涨0.51%报3666.33点，深成指涨0.34%，创业 板指涨0.91%，北证50指数跌0.33%。沪深京三市半日成交额12101亿元，较上日放量605亿元，全市场 超1800只个股上涨。 盘面上，产业创新发展实施意见发布，脑机接口概念走强，麦澜德涨近17%，翔宇医疗涨超10%；港口 航运板块盘中短线拉升，南京港涨停，国航远洋涨近11%；燃气板块全线上涨，东方环宇、新疆火炬、 洪通燃气涨停；地产股普涨，沙河股份、电子城涨停，深振业A涨超8%；银行股集体上涨，农业银行 盘中一度涨近2%续创新高，光大银行、工商银行等涨超1%。 ...

Group 1 - The core viewpoint of the article highlights the significant funding round completed by Zhiran Medical, raising over 300 million yuan, bringing the total financing to nearly 500 million yuan since its establishment in 2022 [2] - The funding will primarily be used for core technology research and large-scale clinical trials, indicating a strong focus on advancing their invasive brain-machine interface technology [2][8] - Zhiran Medical's approach aligns with high-difficulty invasive solutions, utilizing ultra-thin flexible electrodes, which are considered crucial for efficient human-machine interaction [3][5] Group 2 - The company has developed a high-throughput flexible electrode that has received patent authorization in China and the U.S., designed to minimize implantation damage and enhance long-term signal stability [5][7] - A fully implanted high-throughput wireless signal acquisition system has been self-developed, capable of collecting action potentials from 1024 channels, which is complemented by deep neural network algorithms for precise intent decoding [7] - The establishment of a clinical-grade micro-nano processing workshop and GMP workshop allows for a fully controllable process from research and design to mass production, ensuring industrialization for future medical applications [7] Group 3 - The investment community views the invasive brain-machine interface as transitioning from laboratory research to clinical application, with breakthroughs in core technology and systematic implementation being key competitive indicators [8] - The Chinese government has issued policies encouraging the development of high-performance brain signal sensing components and surgical robots, providing a supportive environment for industry growth [8] - The combined effect of technology, capital, and policy is accelerating the clinical and industrialization processes of invasive brain-machine interfaces, making the performance of Zhiran Medical and similar companies a focal point for ongoing observation [8]

今日A股早盘震荡走高，三大指数小幅上涨， 沪指再创年内新高 。 沪深两市半日成交额1.14万亿，较上个交易日放量585亿。盘面上热点较为杂乱， 个股跌多涨少，全市场超3300只个股下跌。 准确 快速 权威 专业 7x24h电报 头条新闻 VIP资讯 实时盯盘 下跌方面，军工股展开调整，捷强装备等跌超5%。板块方面，脑机接口、港口、新疆、液冷服务器等板块涨幅居前，锂矿、军工、稀土永 磁、光伏等板块跌幅居前。截至收盘，沪指涨0.53%，深成指涨0.34%，创业板指涨0.91%。 下载财联社APP获取更多资讯 从板块来看， AI硬件股再度大涨， 胜宏科技等多股再创历史新高，寒武纪涨超15%。脑机接口概念股表现活跃，麦澜德涨超10%。新疆本 地股维持强势，新疆交建等多股3连板。 ...